GeoVax Labs Net Worth
GeoVax Labs Net Worth Breakdown | GOVXW |
GeoVax Labs Net Worth Analysis
GeoVax Labs' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including GeoVax Labs' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of GeoVax Labs' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform GeoVax Labs' net worth analysis. One common approach is to calculate GeoVax Labs' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares GeoVax Labs' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing GeoVax Labs' net worth. This approach calculates the present value of GeoVax Labs' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of GeoVax Labs' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate GeoVax Labs' net worth. This involves comparing GeoVax Labs' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into GeoVax Labs' net worth relative to its peers.
Enterprise Value |
|
To determine if GeoVax Labs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GeoVax Labs' net worth research are outlined below:
GeoVax Labs generated a negative expected return over the last 90 days | |
GeoVax Labs has high historical volatility and very poor performance | |
GeoVax Labs has some characteristics of a very speculative penny stock | |
GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
GeoVax Labs has accumulated 3.52 M in total debt. GeoVax Labs has a current ratio of 0.33, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about GeoVax Labs' use of debt, we should always consider it together with its cash and equity. | |
Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 0. | |
GeoVax Labs has accumulated about 710.68 K in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
GeoVax Labs has a frail financial position based on the latest SEC disclosures | |
Latest headline from MacroaxisInsider: Acquisition by Chase Randal D of 16613 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 |
GeoVax Labs Quarterly Good Will |
|
Project GeoVax Labs' profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.80) | (2.94) | |
Return On Capital Employed | (4.64) | (4.41) | |
Return On Assets | (2.80) | (2.94) | |
Return On Equity | (4.51) | (4.28) |
When accessing GeoVax Labs' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures GeoVax Labs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GeoVax Labs' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in GeoVax Labs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GeoVax Labs. Check GeoVax Labs' Beneish M Score to see the likelihood of GeoVax Labs' management manipulating its earnings.
Evaluate GeoVax Labs' management efficiency
The company has return on total asset (ROA) of (1.3435) % which means that it has lost $1.3435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.6239) %, meaning that it generated substantial loss on money invested by shareholders. GeoVax Labs' management efficiency ratios could be used to measure how well GeoVax Labs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.94 in 2024. Return On Capital Employed is likely to climb to -4.41 in 2024. At this time, GeoVax Labs' Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1.2 M in 2024, whereas Total Assets are likely to drop slightly above 4.9 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.27 | 2.38 | |
Tangible Book Value Per Share | 2.27 | 2.38 | |
Enterprise Value Over EBITDA | (0.27) | (0.29) | |
Price Book Value Ratio | 2.39 | 2.27 | |
Enterprise Value Multiple | (0.27) | (0.29) | |
Price Fair Value | 2.39 | 2.27 | |
Enterprise Value | 7.3 M | 6.9 M |
The management strategies employed by GeoVax Labs' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Revenue 300.7 K | Quarterly Revenue Growth 1.099 | Revenue Per Share 0.143 | Return On Equity (3.62) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeoVax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeoVax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GeoVax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chase Randal D few days ago Acquisition by Chase Randal D of 16613 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 | ||
Mcnally Robert T over a month ago Acquisition by Mcnally Robert T of 50000 shares of GeoVax Labs at 0.755 subject to Rule 16b-3 | ||
Reynolds Mark over six months ago Acquisition by Reynolds Mark of 10000 shares of GeoVax Labs at 0.17 subject to Rule 16b-3 |
GeoVax Labs Earnings per Share Projection vs Actual
GeoVax Labs Corporate Management
CPA CPA | CFO Sec | Profile | |
Mark Newman | Chief Officer | Profile | |
Jeffrey Welch | Head Operations | Profile | |
Harriet Robinson | Chief Founder | Profile | |
John Sharkey | Vice Development | Profile |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.